Fresenius SE KGaA (WBO:FRE) Total Liabilities : €25,633 Mil (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Fresenius SE KGaA Total Liabilities?

Fresenius SE KGaA's Total Liabilities for the quarter that ended in Dec. 2023 was €25,633 Mil.

Fresenius SE KGaA's quarterly Total Liabilities increased from Jun. 2023 (€44,983.00 Mil) to Sep. 2023 (€45,046.00 Mil) but then declined from Sep. 2023 (€45,046.00 Mil) to Dec. 2023 (€25,633.00 Mil).

Fresenius SE KGaA's annual Total Liabilities increased from Dec. 2021 (€42,674.00 Mil) to Dec. 2022 (€44,182.00 Mil) but then declined from Dec. 2022 (€44,182.00 Mil) to Dec. 2023 (€25,633.00 Mil).

Fresenius SE KGaA Total Liabilities Historical Data

The historical data trend for Fresenius SE KGaA's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fresenius SE KGaA Total Liabilities Chart

Fresenius SE KGaA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

40,426.00

40,623.00

42,674.00

44,182.00

25,633.00

Fresenius SE KGaA Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Liabilities	Get a 7-Day Free Trial															44,182.00	44,380.00	44,983.00	45,046.00	25,633.00

Fresenius SE KGaA Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Fresenius SE KGaA's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	9330	+	(13249	+	2301
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	753)
	=	25,633

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	45284	-	19651
	=	25,633

Fresenius SE KGaA's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	9330	+	(13249	+	2301
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	753)
	=	25,633

Total Liabilities	=	Total Assets (Q: Dec. 2023 )	-	Total Equity (Q: Dec. 2023 )
	=	45284	-	19651
	=	25,633

Fresenius SE KGaA Total Liabilities Related Terms

Thank you for viewing the detailed overview of Fresenius SE KGaA's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Fresenius SE KGaA (WBO:FRE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Fresenius SE & Co KGaA (WBO:FRE) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

FSNUY:USA FSNUF:USA FREN:Mexico FRE:Italy FREd:UK 0OO9:UK FRE:Germany

Address

Else-Kroener-Strasse 1, Bad Homburg, HE, DEU, 61352

Website

https://www.fresenius.com

Fresenius SE is a healthcare holding company based in Germany with four segments. The company owns a large stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals and fertility clinics in Germany, Spain, and Latin America. Vamed provides a variety of services such as healthcare facility construction and operation management, including post-acute care rehabilitation.

Fresenius SE KGaA (WBO:FRE) Headlines

No Headlines